The lack of relationship between hepatotoxicity and lithocholic‐acid sulfation in biliary bile acids during chenodiol therapy in the national cooperative gallstone study

To test whether hepatotoxicity occurring in National Cooperative Gallstone Study patients was caused by a toxic effect of chenodiol per se or of lithocholate caused by defective sulfation, bile samples were analyzed using a new high‐performance liquid chromatography method that measures the proportions of the four individual lithocholate amidates (sulfated and unsulfated lithocholylglycine and lithocholyltaurine) and all common bile acid amidates. Samples were obtained from National Cooperative Gallstone Study patients (n = 17) with abnormal light microscopic liver biopsy results or major aminotransferase elevations and from a matched control group of patients (n = 14) who received similar chenodiol doses but had no evidence of liver injury. Bile samples from 45 healthy subjects were also analyzed. The analytical method was validated by showing that the percentage of chenodiol and cholic and deoxycholic acid obtained by highperformance liquid chromatography correlated highly (r > 0.94) with previous gas‐liquid chromatography analyses of these samples by the National Cooperative Gallstone Study Reference Laboratory. No significant differences were seen between gallstone patients with and without evidence of liver injury for percent total lithocholate amidates, percent sulfated or unsulfated lithocholate amidates or percent chenodiol amidates. Lithocholate was partially sulfated in all bile samples (52% ± 17% [mean ± S.D., n = 50]), but the extent of sulfation varied widely between and within patients during the course of therapy. Mean values of healthy subjects were similar and also showed a wide range in the extent of lithocholate sulfation. It is concluded that (a) liver injury caused by these doses of chenodiol could not be attributed to the accumulation of unsulfated lithocholate per se in circulating bile acids; (b) liver injury appeared to be, directly or indirectly, caused by enrichment in circulating bile acids with chenodiol or chenodiol together with lithocholate, suggesting that the hepatocytes of those patients with hepatotoxicity were injured by the change induced in bile‐acid metabolism by the feeding of chenodiol; and (c) about half of lithocholate amidates in bile samples were sulfated, but the extent of sulfation was highly variable both in gallstone patients and healthy subjects.

[1]  S. Shefer,et al.  Early Morphologic and Enzymatic Changes in Livers of Rats Treated with Chenodeoxycholic and Ursodeoxycholic Acids , 2007, Hepatology.

[2]  J. Boyer,et al.  Ultrastructural Evidence of Intrahepatic Cholestasis Before and After Chenodeoxycholic Acid Therapy in Patients with Cholelithiasis: The National Cooperative Gallstone Study , 2007, Hepatology.

[3]  K. Hübner,et al.  Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. , 1989, Gastroenterology.

[4]  L. Combettes,et al.  Release of calcium from the endoplasmic reticulum by bile acids in rat liver cells. , 1988, The Journal of biological chemistry.

[5]  G. Salvioli,et al.  Urinary excretion of bile acids during acute administration in man , 1988, European journal of clinical investigation.

[6]  T. T. Alagaratnam,et al.  No decrease in duodenal ulcer surgery after cimetidine in Hong Kong. , 1988, Journal of clinical gastroenterology.

[7]  S. Ceryak,et al.  Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster. , 1987, Gastroenterology.

[8]  A. Hofmann,et al.  High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. , 1987, Journal of lipid research.

[9]  Y. Chrétien,et al.  IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.

[10]  K. Bergmann,et al.  Biliary cholesterol saturation in non‐obese women and non‐obese men before and after puberty , 1986, European journal of clinical investigation.

[11]  G. Belforte,et al.  Simulation of the metabolism and enterohepatic circulation of endogenous chenodeoxycholic acid in man using a physiological pharmacokinetic model , 1986, European journal of clinical investigation.

[12]  A. Hofmann,et al.  Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit. , 1986, Gastroenterology.

[13]  J. Lachin,et al.  Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study. , 1985, The Journal of laboratory and clinical medicine.

[14]  K. Bergmann,et al.  Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones , 1984 .

[15]  J. Schölmerich,et al.  Influence of Hydroxylation and Conjugation of Bile Salts on Their Membrane‐Damaging Properties‐Studies on Isolated Hepatocytes and Lipid Membrane Vesicles , 1984, Hepatology.

[16]  S. Grundy,et al.  The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS). , 1984, The Journal of clinical investigation.

[17]  N. Hightower,et al.  Major issues in the organization and implementation of the National Cooperative Gallstone Study (NCGS). , 1984, Controlled clinical trials.

[18]  K. Einarsson,et al.  Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. , 1983, Gastroenterology.

[19]  S. Grundy,et al.  Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study. , 1982, Gastroenterology.

[20]  R. Giel,et al.  National Cooperative Gallstone Study: nonprimate toxicology of chenodeoxycholic acid. , 1982, Journal of toxicology and environmental health.

[21]  P. Varady,et al.  Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones. , 1981, The Journal of clinical investigation.

[22]  S. Grundy,et al.  Design and methodological considerations in the National Cooperative Gallstone Study: a multicenter clinical trial. , 1981, Controlled Clinical Trials.

[23]  J. Lachin,et al.  Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety. , 1981, Annals of internal medicine.

[24]  S. Wolfson,et al.  Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey. , 1980, Gastroenterology.

[25]  G. Bonorris,et al.  Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid. , 1980, The Journal of laboratory and clinical medicine.

[26]  B. Kommerell,et al.  Ursodeoxycholic acid versus chenodeoxycholic acid: Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones , 1978 .

[27]  A. Hofmann,et al.  Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. , 1978, Gastroenterology.

[28]  R. Naeye.  Causes and consequences of placental growth retardation. , 1978, JAMA.

[29]  P. Klein,et al.  Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response. , 1978, JAMA.

[30]  E. Palmer.  Zenker's Diverticulum Develops Superior to the Cricopharyngeus Muscle , 1977 .

[31]  F. Schmidt,et al.  [Alterations of bile acid metabolism during treatment with chenodeoxycholic acid. Studies of the role of the appearance of ursodeoxycholic acid in the dissolution of gallstones (author's transl)]. , 1976, Klinische Wochenschrift.

[32]  J. Thistle,et al.  Lithocholate metabolism during chemotherapy for gallstone dissolution. 2. Absorption and sulphation. , 1976, Gut.

[33]  J. Thistle,et al.  Lithocholate metabolism during chenotherapy for gallstone dissolution. 1. Serum levels of sulphated and unsulphated lithocholates. , 1976, Gut.

[34]  T. Gadacz,et al.  Impaired lithocholate sulfation in the rhesus monkey: a possible mechanism for chenodeoxycholate toxicity. , 1976, Gastroenterology.

[35]  A. Hofmann,et al.  Metabolism of lithocholate in healthy man. III. Plasma disappearance of radioactivity after intravenous injection of labeled lithocholate and its derivatives. , 1975, Gastroenterology.

[36]  A. Hofmann,et al.  Metabolism of lithocholate in healthy man. II. Enterohepatic circulation. , 1975, Gastroenterology.

[37]  A. Hofmann,et al.  Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates. , 1975, Gastroenterology.

[38]  J. Deitrick,et al.  Toxicity of chenodeoxycholic acid in the nonhuman primate. , 1975, Surgery.

[39]  M. Lancaster,et al.  Influence of primary bile acid feeding on cholesterol metabolism and hepatic function in the rhesus monkey. , 1975, Mayo Clinic proceedings.

[40]  A. Hofmann,et al.  Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. , 1975, Gut.

[41]  N. LaRusso,et al.  Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. , 1975, Gut.

[42]  A. Hofmann,et al.  Metabolism of Steroid and Amino Acid Moieties of Conjugated Bile Acids in Man: IV. Description and validation of a multicompartment model , 1974 .

[43]  J. Thistle,et al.  Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis. , 1973, The Journal of clinical investigation.

[44]  M. M. Fisher,et al.  Bile acid metabolism in mammals. V. Studies on the sex difference in the response of the isolated perfused rat liver to chenodeoxycholic acid. , 1973, Canadian Journal of Physiology and Pharmacology.

[45]  R. Palmer.  Bile acids, liver injury, and liver disease. , 1972, Archives of internal medicine.

[46]  M. M. Fisher,et al.  Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic and chenodeoxycholic acids in the rat. , 1971, Laboratory investigation; a journal of technical methods and pathology.

[47]  S. Grundy,et al.  QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. , 1965, Journal of lipid research.

[48]  P. Eneroth,et al.  On the turnover and excretory products of cholic and chenodeoxycholic acid in man. , 1963, The Journal of biological chemistry.

[49]  R L Habig,et al.  Central laboratory quality control in the National Cooperative Gallstone Study. , 1983, Controlled clinical trials.

[50]  G. Salen,et al.  Hepatic toxicity in the rhesus monkey treated with chenodeoxycholic acid for 6 months: biochemical and ultrastructural studies. , 1976, Gastroenterology.

[51]  B. Kommerell,et al.  Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment. , 1975, Digestion.

[52]  N. Hoffman,et al.  Metabolsim of steroid and amino acid moieties of conjugated bile acids in man. , 1974, Gastroenterology.